ALX Oncology Holdings, Inc. (ALXO)
1.17
-0.02
(-1.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings EPS Diluted (Quarterly) : -0.1325 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1325 |
| March 31, 2026 | -0.1714 |
| December 31, 2025 | -0.4209 |
| September 30, 2025 | -0.4133 |
| June 30, 2025 | -0.4855 |
| March 31, 2025 | -0.5764 |
| December 31, 2024 | -0.5523 |
| September 30, 2024 | -0.5827 |
| June 30, 2024 | -0.7601 |
| March 31, 2024 | -0.7099 |
| December 31, 2023 | -0.9281 |
| September 30, 2023 | -1.239 |
| June 30, 2023 | -0.8357 |
| March 31, 2023 | -0.7387 |
| December 31, 2022 | -0.7535 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.8668 |
| June 30, 2022 | -0.8091 |
| March 31, 2022 | -0.604 |
| December 31, 2021 | -0.7017 |
| September 30, 2021 | -0.6081 |
| June 30, 2021 | -0.4044 |
| March 31, 2021 | -0.3541 |
| December 31, 2020 | -0.4712 |
| September 30, 2020 | -0.3627 |
| June 30, 2020 | -0.378 |
| March 31, 2020 | -0.2038 |
| December 31, 2019 | -0.2421 |
| September 30, 2019 | -0.1128 |
| June 30, 2019 | -0.1401 |
| March 31, 2019 | -0.141 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.97M |
| Total Expenses (Quarterly) | 17.97M |
| Enterprise Value | 34.52M |
| Earnings Yield | -97.27% |
| Normalized Earnings Yield | -96.98 |